Skylight Psychedelics

Author name: loafa

San Francisco decriminalizes psychedelics

By Max Savage Levenson, 9/7/2022 Last night, Sept. 6, the San Francisco Board of Supervisors gave unanimous approval to a resolution that effectively decriminalizes entheogens and their compounds for adult use. The resolution defines entheogens as the “full spectrum of plants, fungi, and natural materials that can inspire personal and spiritual well-being.” That list includes […]

San Francisco decriminalizes psychedelics Read More »

Psychedelic drug helped people with alcohol use disorder reduce drinking, study shows

Psilocybin, the ingredient in magic mushrooms, along with talk therapy, showed significant benefit in the largest clinical trial of its kind. By Kaitlin Sullivan, Akshay Syal, M.D., Kori Lynch and Harry Smith Two doses of psilocybin pills, along with psychotherapy, helped people with alcohol use disorder reduce drinking for at least eight months after their

Psychedelic drug helped people with alcohol use disorder reduce drinking, study shows Read More »

NYU Study Examines the Ability of Psilocybin to Treat Heavy Drinking:

As the psychedelic renaissance continues, research is constantly evolving and revealing the powerful therapeutic potential of these medications. A recent study from New York University looked at the potential for psilocybin, the active ingredient in “magic mushrooms”, to alleviate problem drinking. So far, the evidence is encouraging. This is what the study looked at: 93

NYU Study Examines the Ability of Psilocybin to Treat Heavy Drinking: Read More »

New Study Estimates Over 5.5 Million U.S. Adults Use Hallucinogens

PAST 12-MONTH LSD USE RATE INCREASED FROM 0.9 PERCENT IN 2002 TO 4 PERCENT IN 2019 Hallucinogen use has increased since 2015, overall and particularly among adults 26 and older, while use decreased in adolescents aged 12–17 years according to a new study by Columbia University Mailman School of Public Health and Columbia University Irving

New Study Estimates Over 5.5 Million U.S. Adults Use Hallucinogens Read More »

VR is as good as psychedelics at helping people reach transcendence

On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms. By Hana Kirosarchive –  8/6/2022 Fifteen years ago, David Glowacki was walking in the mountains when he took a sharp fall. When he hit the ground, blood began leaking into his lungs. As he

VR is as good as psychedelics at helping people reach transcendence Read More »

Morgan Stanley Positive in First Psychedelics Research Report

By Bryan Mc Govern – 8/3/2022 The psychedelics industry received a boost in confidence this week by way of a new market report from banking giant Morgan Stanley. Morgan Stanley (NYSE:MS) has shared its first official commentary on the psychedelics industry. The concept of investing in psychedelic medicine received a legitimate vote of confidence of

Morgan Stanley Positive in First Psychedelics Research Report Read More »

Women with PTSD Show Accelerated Cognitive Decline in Midlife

By Jolynn Tumolo – 07/12/2022 Post-traumatic stress disorder (PTSD) was associated with accelerated cognitive decline in middle-aged women, according to a large-scale prospective cohort study published in JAMA Network Open. “Given that cognitive decline is associated with subsequent Alzheimer disease and related dementias, better understanding of this association may be important to promote healthy aging,”

Women with PTSD Show Accelerated Cognitive Decline in Midlife Read More »

Psychedelic Medicine – A New Era In Mental Health Treatment:

At Skylight Psychedelics, we recognize that the era of psychedelic medicine is here, and with it comes new hope for people struggling with depression, trauma from PTSD, anxiety and addiction. Hobbled for decades by draconian federal regulations, psychedelic medicines like ketamine, psilocybin, MDMA, LSD, DMT, mescaline, ayahuasca and iboga are becoming increasingly recognized by the

Psychedelic Medicine – A New Era In Mental Health Treatment: Read More »

Ketamine: Treats Depression and Severe Trauma Rapidly by Regenerating Neurons in the Brain

Depression and PTSD are some of the most debilitating public health problems we currently face. Depression affects men, women, adults, adolescents and children, and the estimated annual cost of depression is over $2 Billion per year. People who suffer from depression endure persistent feelings of hopelessness, fatigue, lack of the ability to enjoy life, poor

Ketamine: Treats Depression and Severe Trauma Rapidly by Regenerating Neurons in the Brain Read More »

Shopping cart0
There are no products in the cart!
Continue shopping
0